Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01166334 · ClinicalTrials.gov registry record · Phase 1
WebQuit Online Smoking Cessation Study
A Phase 1 study, sponsored by Fred Hutchinson Cancer Center.
- Completed
- Registry status
- Phase 1
- Development phase
- 721
- Enrollment target
NCT01166334: Completed Phase 1 study, sponsored by Fred Hutchinson Cancer Center.
NCT01166334 is a Phase 1 study that has completed, run by Fred Hutchinson Cancer Center. The registered enrollment target is 721 participants, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (1102% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01166334, a Phase 1 study, has completed, sponsored by Fred Hutchinson Cancer Center.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 721 participants
- Enrollment target
Study Summary
Would you like to quit smoking? Seattle's Fred Hutchinson Cancer Research Center is launching a new study that may be able to help. Participants who enroll in this study will be randomly assigned by computer (like flipping a coin) to one of two online programs. The goal of this study is to learn which of these programs is the most effective at helping people stop smoking. Findings from this study will be used to help build more effective online smoking cessation programs in the future. Participants in both of the smoking cessation programs used in this study will receive: * Interactive tools for dealing more effectively with urges to smoke * Step-by-step guides for quitting smoking * Personalized plans for quitting and remaining smoke-free * Electronic links for reaching one-on-one expert help for quitting Participants will be asked to complete online questionnaires, including a brief three-month follow-up survey. There is no cost for participating in this study. To enroll in this study or for more information, please visit www.webquit.com. This study is being conducted by Seattle's Fred Hutchinson Cancer Research Center (www.fhcrc.org), a world leader in advancing the prevention, diagnosis and treatment of cancer. The principal investigator for the WebQuit smoking cessation study is Dr. Jonathan Bricker, a faculty member at both the Hutchinson Center and at the University of Washington in Seattle.
Primary Outcome
No smoking in the past 7 days, as reported 3 months post treatment.
Interventions
- BEHAVIORAL WebQuit study group
- BEHAVIORAL WebQuit control group
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 721 participants |
| Start Date | 2010-06 |
| Est. Completion | 2012-01 |
| Phase | Phase 1 |
What the finished NCT01166334 record still lists
NCT01166334 is an interventional study that assigns participants to a tested intervention. The registered 721 participants enrollment target is mid-sized for trials with a published cap, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (1102% higher).
The record links to 0 conditions, and to 2 interventions - of which WebQuit study group is the first listed.
NCT01166334 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01166334 about?
NCT01166334 is a clinical study titled "WebQuit Online Smoking Cessation Study". Would you like to quit smoking? Seattle's Fred Hutchinson Cancer Research Center is launching a new study that may be able to help. Participants who enroll in this study will be randomly assigned by computer (like flipping a coin) to one of two online programs. The goal of this study is to learn wh...
What is the current status of trial NCT01166334?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 721 participants. The study started on 2010-06. Estimated completion is 2012-01.
What interventions are being tested in trial NCT01166334?
The interventions under investigation include: WebQuit study group (BEHAVIORAL), WebQuit control group (BEHAVIORAL).
Who is sponsoring clinical trial NCT01166334?
This trial is sponsored by Fred Hutchinson Cancer Center, which has 483 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01166334's enrollment target sits among peer trials
721 18th of 2000 higher than 1,983 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06116149 · 722 participants · NA
Strategies for Implementing a Postpartum Lifestyle Intervention in WIC Clinics
- NCT04916327 · 720 participants · NA
Examining the Impact of Exercise Training on Vascular Dysfunction in Individuals With Mental Health Disorders - Study 1
- NCT05047224 · 720 participants · NA
Addressing Disparities in Autism Spectrum Disorder Diagnosis Using a Direct-to-home Telemedicine Tool
- NCT05309395 · 720 participants · Phase 3
Food Prescriptions to Promote Affordable Diets
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia